SM Nidorf, E Ben-Chetrit,
PM Ridker - European Heart Journal, 2024 - academic.oup.com
Abstract Low-dose colchicine (0.5 mg daily) is now FDA-approved for secondary prevention
in patients with coronary disease and will be increasingly prescribed in clinical practice. In …